Medical Communications

Valeant has announced the appointment of Paul S. Herendeen as executive vice president, who will also take over as chief …

The end of another week, and from huge expansions and investments to some shocking and saddening tragedies, it’s been a …

The European Commission has granted marketing authorisation for Teva’s Cinqaero (reslizumab), as an odd-on therapy in adult patients with severe …

NICE has deemed Bayer’s liver cancer drug Nexavar (sorafenib) as not cost-effective. The drug is currently available on the Cancer …

Valeant Pharmaceuticals has confirmed that it is being sued by one its former largest shareholders, T Rowe Price, who claim …

Intercept Pharmaceuticals have announced the publication of Phase III results published in the New England Journal of Medicine, where Ocaliva …

China’s state-backed developer Greenland Holdings is set to jointly invested over $1 billion in a San Francisco-based biotech industrial park …

The National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Xalkori (crizotinib) as a treatment for lung cancer, …

Ashfield, part of UDG Healthcare plc (LON: UDG), a global leader in providing outsourced healthcare services to pharmaceutical, device and …

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …

The priorities of Pharma and healthcare organisations are better aligned as a result of the industry’s increased efforts to put …

A new report from the Centers for Disease Control and Prevention (CDC) has highlighted a sharp increase in the number …

Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …

Novartis has confirmed that six employees in South Korea gave kickbacks to doctors, as the current and former employees face …

Advaxis, a US biotech in cancer immunotherapy development, has announced that its lead immunotherapy product axalimogene filolisbac (AXAL) has hit …